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Hematopoietic stem cells are formed during embryonic development, and serve as the foundation of the
deﬁnitive blood program for life. Notch signaling has been well established as an essential direct con-
tributor to HSC speciﬁcation. However, several recent studies have indicated that the contribution of
Notch signaling is complex. HSC speciﬁcation requires multiple Notch signaling inputs, some received
directly by hematopoietic precursors, and others that occur indirectly within neighboring somites. Of
note, proinﬂammatory signals provided by primitive myeloid cells are needed for HSC speciﬁcation via
upregulation of the Notch pathway in hemogenic endothelium. In addition to multiple requirements for
Notch activation, recent studies indicate that Notch signaling must subsequently be repressed to permit
HSC emergence. Finally, Notch must then be reactivated to maintain HSC fate. In this review, we discuss
the growing understanding of the dynamic contributions of Notch signaling to the establishment of
hematopoiesis during development.
& 2015 Elsevier Inc. All rights reserved.1. Introduction
Hematopoietic stem cells (HSCs) are the foundation of the
vertebrate blood system. These stem cells self-renew to maintain a
steady pool of HSCs that can differentiate as needed into cells of
the lymphoid, myeloid and erythroid lineages, and thereby
maintain blood cell homeostasis for life. Thus far it has not been
possible to derive HSCs in vitro from pluripotent precursors, ne-
cessitating a deeper understanding of the mechanisms leading to
their development in vivo. HSCs are born during embryonic de-
velopment, though the molecular mechanisms governing their
emergence are not completely understood. In recent years, it has
become clear that the dynamic context of the developing verte-
brate embryo provides numerous molecular and environmental
cues critical for HSC formation, including the Notch signaling
pathway (Clements and Traver, 2013).
The generation of HSCs during embryonic development is de-
pendent upon Notch signaling (Kumano et al., 2003). Within wild-
type/Notch1/ chimeric mice, Notch1-null cells fail to con-
tribute to hematopoiesis, indicating that the Notch1 receptor is
required cell-autonomously, for HSC potential (Hadland et al.,
2004). In both mice and zebraﬁsh, Notch signaling functions ge-
netically upstream of the transcription factor Runx1 (Burns et al.,
2005; Nakagawa et al., 2006), which is essential prior to HSC
emergence (Chen et al., 2009; Kissa and Herbomel, 2010). Al-
though Notch signaling provides direct transcriptional regulationof several genes that are important for HSC formation, including
Hes1, Hes5, Hey2 and Gata2 (Davis and Turner, 2001; Guiu et al.,
2013; Tsai et al., 1994; Iso et al., 2003; Robert-Moreno et al., 2005),
Notch does not appear to directly regulate Runx1 expression (Ro-
bert-Moreno et al., 2005; Nottingham et al., 2007). Rather, a
transcriptional complex including Gata2 drives Runx1 expression
within the hemogenic endothelium from which HSCs derive
(Nottingham et al., 2007), providing a deﬁned, cell-autonomous
link between receipt of Notch activation and the emergence of
HSCs. Interestingly, the hematopoietic defect that occurs in the
absence of Notch signaling can be rescued by the artiﬁcial induc-
tion of Runx1 but not Gata2 (Nakagawa et al., 2006). This strongly
indicates that Notch signaling regulates additional, unknown fac-
tors required for Runx1 induction.
Although it is well established that Notch signaling is required
cell-autonomously for HSC formation (Kumano et al., 2003; Had-
land et al., 2004), recent evidence has revealed that the Notch
signaling pathway exerts complex regulation of HSC speciﬁcation,
emergence and maintenance in the developing embryo. It is now
apparent that multiple, distinct Notch signaling events act in both
direct and indirect ways, and provide both positive and negative
regulation over the establishment of the adult hematopoietic
system.2. Mechanisms of Notch signaling
Notch signaling allows for communication between cells in
close contact, through the binding of ligands and receptors on
E. Butko et al. / Developmental Biology 409 (2016) 129–138130adjacent cells. Notch family receptors consist of single-pass
transmembrane proteins, including an extracellular domain made
up of ligand-binding EGF repeats, a membrane-tethered tran-
scriptionally active intracellular domain and multiple proteolytic
cleavage sites allowing for separation of these components upon
ligand binding. The Notch signal initiates when a ligand of the
Delta/Serrate/Lag-2 (DSL) family on the signal-sending cell inter-
acts directly with a Notch receptor on the signal-receiving cell.
Within the signal-sending cell, ubiquitination of the ligand by the
E3 ubiquitin ligases Mindbomb (Chen and Corliss, 2004; Itoh et al.,
2003) and Neuralized (Deblandre et al., 2001; Yeh et al., 2001;
Pavlopoulos et al., 2001; Lai et al., 2001) promote Notch activation
by stimulating endocytosis of the receptor-bound ligand. The re-
sulting tension exposes the S2 proteolytic cleavage site at the base
of the Notch receptor extracellular domain, near the cell mem-
brane, facilitating S2 cleavage by ADAM family metalloproteases
(Gordon et al., 2007; Nichols et al., 2007; Parks et al., 2000).
Subsequently, the remaining membrane-tethered receptor is
cleaved by γ-secretase from the S3 to S4 cleavage sites, releasing
the Notch intracellular domain (NICD) and allowing its transloca-
tion to the nucleus. In the most established model of Notch tran-
scriptional regulation, the Notch transcriptional partner RBPjK
recruits nuclear corepressor (NcoR) and histone deacetylases
(HDACs) and holds Notch target genes in a transcriptionally re-
pressed state in the absence of Notch signaling (Fig. 1A) (Kao et al.,
1998). Upon Notch activation, nuclear NICD displaces these tran-
scriptional corepressors and recruits coactivators such as Mas-
termind, initializing transcription of direct Notch targets. Although
according to this traditionally accepted model, RBPjK actively re-
presses activation of Notch targets in the absence of Notch sig-
naling, recent work has indicated that Notch transcriptional reg-
ulation may be more complex than previously realized. Rather
than constantly occupying Notch-responsive enhancer elements,
in many cases RBPjK is recruited alongside NICD, suggesting thatN
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Fig. 1. Overview of Notch Signaling: (A) Notch receptors are activated by binding of th
families on adjacent signal-sending cell. Ubiquitination of Notch ligands by the Mindbom
ADAM family metalloproteases through exposure of the S2 proteolytic cleavage site.
transmembrane receptor. Subsequently, the ligand–NECD complex is taken up by the sig
S3 and S4 proteolytic sites by Gamma-Secretase, releasing the Notch intracellular domain
In the absence of Notch receptor activation, Notch transcriptional targets are bound by
repressed state. Nuclear NICD binds RBPjK, displacing the corepressor complex and allo
tional coactivators (Co-A), allowing for transcriptional activation of Notch target genes. (B
manner. In this case, RBPjK does not occupy the Notch target site in the absence of N
scriptional co-activators.RBPjK does not repress all Notch targets prior to Notch activation
(Fig. 1B) (Castel et al., 2013). It remains unclear whether RBPjK
functions as a steady-state repressor for direct Notch targets in the
context of HSC formation.
Induction of Notch signaling allows coordinated cell fate deci-
sions amongst neighboring cells, through lateral inhibition or
lateral induction mechanisms (Lewis, 1998; Artavanis-Tsakonas
et al., 1999). Lateral inhibition occurs when stochastic differences
between cells result in Notch activation in one neighbor, and this
activation results in the transcriptional repression of Notch ligand
in the signal receiving, Notch-active cell. The resulting negative
feedback loop enforces directionality of Notch activation, and can
drive adjacent cells of shared developmental origin to distinct
fates. In contrast, lateral induction occurs when Notch activation
results in increased expression of Notch ligand on the signal re-
ceiving, Notch-active cell. In lateral induction, Notch signaling in-
duces positive feedback. As Notch-active cells become Notch-ac-
tivators, elevated levels of Notch activity drive adjacent cells to the
same fate. Lateral induction results in clusters of Notch-active
cells, lateral inhibition creates a “salt and pepper” arrangement of
Notch-active cells amongst Notch-inactive neighbors by restricting
Notch activation (Artavanis-Tsakonas et al., 1999; Bigas et al.,
2010).3. Origins of the hematopoietic system
Vertebrate hematopoiesis begins during embryogenesis with
several independent waves of blood formation preceding the
eventual emergence of deﬁnitive HSCs, which will establish and
maintain the adult blood program. This process initiates with the
independent generation of primitive myeloid and primitive ery-
throid cells, which both arise transiently without a sustained pool
of progenitors. Primitive erythroid cells and endothelial cells ariseN
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e Notch extracellular domain (NECD) to Notch ligands of the Delta/Serrate/Lag-2
b and Neuralized E3 ubiquitin ligases promotes endocytosis, facilitating cleavage by
S2 cleavage results in the separation of ligand-bound NECD, and the remaining
nal-sending cell. The remaining membrane-bound Notch receptor is cleaved at the
(NICD) from the membrane tether and allowing NICD to translocate to the nucleus.
RBPjK/CSL and transcriptional corepressors (Co-R), and held in a transcriptionally
wing for the recruitment of transcriptional partner Mastermind (MAM) and addi-
) In some cases RBPjK occupies Notch transcriptional target sites in a more dynamic
otch activation, and is instead recruited upon activation alongside NICD and tran-
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vinsky et al., 2011). Primitive erythrocytes and endothelial cells
derive from a shared “hemangioblast” mesodermal precursor,
during gastrulation that differentiates into distinct hematopoietic
and endothelial lineages prior to reaching the yolk sac (Huber
et al., 2004). Embryo-derived primitive myeloid cells arise with
restricted potential from the yolk sac shortly following primitive
erythrocyte formation (Dzierzak and Speck, 2008; Bertrand et al.,
2005). Multipotent erythromyeloid progenitor (EMP) cells, which
give rise to both deﬁnitive erythroid and myeloid lineages, emerge
shortly after primitive erythropoiesis and myelopoiesis, also from
the yolk sac (Palis et al., 1999). Whereas primitive erythrocytes
arise from a shared endothelial precursor, EMPs were recently
suggested to derive from the endothelium itself in the murine yolk
sac (Chen et al., 2011). Embryonic hematopoiesis culminates with
the generation of HSCs, the only cells capable of long-term self-
maintenance and differentiation into a full repertoire of
hematopoietic lineages. In the mouse, HSCs have been reported to
emerge from hemogenic endothelium primarily within the dorsal
aorta, from the umbilical and vitelline arteries, and the placenta
(Jaffredo et al., 1998, 2000; Rhodes et al., 2008; Gordon-Keylock
et al., 2013; de Bruijn et al., 2000) HSCs have also been reported to
emerge within the head vasculature and heart, although these
ﬁndings are controversial (Li et al., 2012; Nakano et al., 2013).
Although lower vertebrates develop externally to the parent
and lack an extraembryonic yolk sac, hematopoiesis likewise
proceeds through four waves, via cellular and molecular me-
chanisms that appear to be largely conserved. In this regard, work
in zebraﬁsh and Xenopus has helped clarify the developmental
origins of embryonic and adult blood cells. In mammals, lineage
restricted primitive erythrocytes and primitive myeloid cells arise
during a similar period within the yolk sac, however work in
zebraﬁsh has deﬁned distinct mesodermal origins of these two
populations. Primitive myeloid cells derive from the anterior lat-
eral plate mesoderm (ALM), and differentiate within the rostral
blood island, on the anterior region of the yolk ball (Herbomel
et al., 1999). In contrast, primitive erythrocytes, EMPs and HSCs are
thought to share a common origin within the posterior lateral
plate mesoderm (PLM) of zebraﬁsh, which is analogous to the
dorsal lateral plate (DLP) of Xenopus. In both species, cells within
this bilateral mesodermal population undergo commitment to
primitive hematopoietic or endothelial fate, followed by medial
migration, convergence at the midline, and the initiation of vas-
culogenesis (Medvinsky et al., 2011). The formation of HSCs from
hemogenic endothelium of the dorsal aorta is conserved from
humans to zebraﬁsh (Medvinsky et al., 2011). Of the four em-
bryonic waves of vertebrate hematopoiesis, Notch signaling is es-
sential only for the establishment of HSCs (Kumano et al., 2003;
Burns et al., 2005; Bertrand et al., 2010; Gering and Patient, 2005),
although it also appears to inﬂuence the development of primitive
erythrocytes (Robert-Moreno et al., 2007).4. A role for Notch signaling in hematovascular fate
determination
Signaling involved in mesodermal commitment to an en-
dothelial fate precedes HSC development. In both mice and zeb-
raﬁsh, primitive erythrocytes and endothelium arise from a shared
hemangioblast precursor (Huber et al., 2004; Vogeli et al., 2006).
Multiple studies in zebraﬁsh have postulated that Notch signaling
inﬂuences the development of endothelial and primitive erythroid
cells from the PLM (Chun et al., 2011; Lee et al., 2009). In one
study, Notch activation in the early zebraﬁsh embryo led to in-
creased numbers of primitive erythrocytes and a corresponding
decrease in endothelial cells, suggesting that Notch signalinginﬂuences the determination of endothelial versus primitive ery-
throid fate (Lee et al., 2009), consistent with its role in lateral in-
hibition. More recently, however, Notch signaling has been re-
ported to promote the proliferation of endothelial precursors
within the PLM (Chun et al., 2011). Additionally, the gain of Notch
signaling that occurs with the loss of Notch inhibitors numb and
numb-like results in primitive erythroblasts that fail to mature and
instead undergo apoptosis (Bresciani et al., 2010), indicating that
Notch signaling inhibition promotes primitive erythrocyte survi-
val. Accordingly, murine RBPjK mutants experience an elevated
number of primitive erythrocytes, due to reduced levels of apop-
tosis (Robert-Moreno et al., 2007), whereas the zebraﬁsh Notch
signaling mutant mindbomb shows no noticeable reduction in
primitive erythrocytes (Burns et al., 2005). Presently, it appears
that Notch signaling may independently promote endothelial
lineage expansion within the PLM and the maintenance of pri-
mitive erythrocytes as they undergo differentiation. Further study
is necessary to elucidate any contribution of Notch signaling to fate
determination within lateral plate mesoderm.5. Notch signaling in arterial speciﬁcation
Hematopoietic stem cells are produced from the major arterial
vessels, most robustly from the ventral wall of the dorsal aorta,
with additional contributions from the vitelline and umbilical ar-
teries in the mouse (Jaffredo et al., 1998, 2000; Gordon-Keylock
et al., 2013; de Bruijn et al., 2000). Early observations of the close
association between the major arterial vessels and the earliest
hematopoietic clusters (Jordan, 1917) and the determination that
these regions are the ﬁrst to generate HSCs, led to the long-
standing hypothesis that arterial speciﬁcation is a prerequisite to
HSC formation (de Bruijn et al., 2000; Garcia-Porrero et al., 1995).
Endothelial cells and HSCs share a common mesodermal origin
across vertebrate species (Huber et al., 2004; Ciau-Uitz et al., 2010;
Nishikawa et al., 1998; Pola et al., 2001). Within the endothelial
lineage, the major arterial vessels in particular give rise to HSCs,
suggesting arterial speciﬁcation may be an intermediate step ne-
cessary for HSC formation. This idea has been bolstered by the lack
of venous contribution to HSCs, and by shared requirements for
Hedgehog, VEGF, and Notch signaling in both arterial speciﬁcation
and HSC emergence.
Mechanistically, work in zebraﬁsh has shown that Hedgehog
secreted from the notochord and ﬂoor plate stimulates the pro-
duction of vascular endothelial growth factor a (Vegfa) from so-
mitic tissues (Lawson et al., 2002). Both Hedgehog and VEGF sig-
naling pathways are required for the migration of endothelial
progenitors, lumenization during primary vasculogenesis, and ar-
terial speciﬁcation (Lawson et al., 2002; Williams et al., 2010;
Vokes et al., 2004; Brown et al., 2000; Wilkinson et al., 2012;
Cleaver and Krieg, 1998). Hedgehog and Vegfa both function up-
stream of Notch signaling in the speciﬁcation of arterial identity
(Lawson et al., 2001, 2002). Notch promotes arterial speciﬁcation
at least in part through the direct regulation of the arterial ligand
EphrinB2 (Grego-Bessa et al., 2007), which together with its ve-
nous receptor, EphB4, mediates the segregation of venous and
arterial cells into distinct vessels by forward and reverse Eph/
Ephrin transmembrane signaling (Adams et al., 1999, 2001; Foo
et al., 2006; Wang et al., 1998; Herbert et al., 2009). Downstream
of Hedgehog and Vegfa, Notch activation bestows both arterial
identity (Gering and Patient, 2005; Herbert et al., 2009; Lawson
et al., 2003) and HSC fate from hemogenic endothelium (Gering
and Patient, 2005; Kim et al., 2013; Burns et al., 2009), placing
Notch signaling as an essential downstream effector of this sig-
naling axis (Fig. 2A).
Establishment of arterial fate begins far in advance of
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zebraﬁsh embryo (Quillien et al., 2014). In developing zebraﬁsh
embryos, the Hes-related transcription factor hey2 promotes ar-
terial fate determination within the early PLM, and loss of Hey2results in severe defects in vasculogenesis and lack of arterial ex-
pression (Zhong et al., 2001; Weinstein et al., 1995; Zhong et al.,
2000; Rowlinson and Gering, 2010). Although murine Hey2 mu-
tants have only mild vascular defects (Iso et al., 2003; Gessler et al.,
2002), the combined loss of Hey1 and Hey2 results in severe de-
fects in arterial speciﬁcation and vascular morphogenesis, simi-
larly to zebraﬁsh hey2 mutants and reminiscent of murine Notch1-
null embryos (Fischer et al., 2004; Kokubo et al., 2005), suggesting
a conserved role of Hey transcription factors in the establishment
of functional vasculature.
In zebraﬁsh, Hey2 functions downstream of Hedgehog and
Vegfa, but its expression is maintained in mindbomb Notch sig-
naling mutants (Lawson et al., 2001; Rowlinson and Gering, 2010).
Hey2 is required for arterial expression of notch1b and ephrinB2a,
and hemogenic endothelial expression of runx1 and cmyb (Wein-
stein et al., 1995; Zhong et al., 2000; Rowlinson and Gering, 2010).
Both arterial and hematopoietic defects in hey2 morphants are
rescued by restoration of Notch signaling, placing Hey2 as a key
initiator of arterial speciﬁcation in zebraﬁsh (Rowlinson and Ger-
ing, 2010). Although Hey2 has not been reported to function up-
stream of Notch signaling in mice, the Hey2 transcriptional co-
regulators Foxc1 and Foxc2 are required for expression of Notch1,
Notch4, Dll4, Jag1, as well as EphrinB2 (Seo et al., 2006; Hayashi
and Kume, 2008), allowing for the possibility that Hey2 may act
upstream of Notch signaling during the initiation of mammalian
arterial speciﬁcation.
Several ligands and receptors of Notch signaling are expressed
in the dorsal aorta during the period of arterial and hematopoietic
speciﬁcation. Within the E9.5-10.5 aorta, at the time HSPC clusters
are formed, the Dll4, Jag1 and Jag2 ligands and Notch1 and Notch4
receptors are arterially expressed (Robert-Moreno et al., 2008).
Notch1 is essential for arterial speciﬁcation, and is required cell-
autonomously for HSC formation (Kumano et al., 2003; Hadland
et al., 2004; Krebs et al., 2000, 2004). Although Notch4 is dis-
pensable for normal arteriogenesis, it may provide some con-
tribution to vascular development as Notch1/Notch4 double mu-
tants fail to form lumenized vessels and have a more severe
phenotype than Notch1 mutants alone (Krebs et al., 2000). Dll4
expression is initiated within arterial cells downstream of Vegfa
(Hayashi and Kume, 2008). Both homozygous and heterozygous
Dll4 mutants are embryonic lethal, with broad vascular defects
prior to HSC emergence (Krebs et al., 2004; Duarte et al., 2004). In
contrast, Dll4 overexpression results in the ectopic expansion of
arterial markers to the venous endothelium, including Hey1,
Notch1, and EphrinB2, suggesting that Dll4 is sufﬁcient to initiate
the arterial Notch programwithin endothelial cells (Trindade et al.,
2008).
Notch signaling itself is required for the expression of a numberFig. 2. Multiple contributions of Notch signaling surrounding HSC speciﬁcation in
zebraﬁsh embryos. (A) Establishment of Arterial Identity: Hedgehog secreted by the
notochord stimulates the production of Vegfa from the somites, initiating the ar-
terial program including Notch ligand and receptor expression. (B) Somite-Intrinsic
Notch Signaling: Non-canonical Wnt ligand Wnt16 controls the pro-hematopoietic
somitic expression of Notch ligands deltaC and deltaD. Fgf signaling downstream of
Wnt16 is required for somitic deltaC, but not deltaD expression. Activation of the
somitic Notch3 receptor, possibly via the DeltaC/D ligands, promotes HSPC speci-
ﬁcation, possibly by regulation of the organization or function of the sclerotome
compartment. (C) Somite-to-PLM Notch signaling: During medial convergence of
the posterior lateral plate mesoderm, direct cell contact allows for Notch signaling
between DeltaC and DeltaD ligands on the ventral face of the somite and Notch
receptors on migrating arterial cells. (D) Vasculogenesis: Direct arterial Notch tar-
get EphrinB2, together with venous EphB4, promotes arteriovenous segregation
and the vasculogenesis. Formation of intact vasculature is required for the estab-
lishment of circulation and for circulation-dependent hemogenic endothelial
maintenance. F. Proinﬂammatory signaling. Production of TNFα by primitive neu-
trophils signals through Tnfr2 to promote arterial expression of jag1a. Jag1a is re-
quired for HSPC formation, possibly through endothelial-intrinsic signaling with
the Notch1a receptor.
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Notch signaling is required for arterial expression of the ligands
Jag1 and Jag2, and for expression of the Notch1 receptor (Robert-
Moreno et al., 2005), suggesting these factors might be regulated
by a primary Notch signaling event within the endothelium. Si-
milarly, Notch signaling is required for the expression of deltaC and
notch3 within the dorsal aorta of embryonic zebraﬁsh (Lawson
et al., 2001). The conserved regulation of Notch ligands and re-
ceptors by Notch signaling suggests that multiple, sequential
Notch signaling events occur within the dorsal aorta.
Jag1 mutant embryos undergo normal arterial development,
but within the dorsal aorta, both hematopoietic gene expression
within the hemogenic endothelium and hematopoietic cluster
formation are reduced (Robert-Moreno et al., 2008). Notch1 and
Jag1 are expressed in a salt-and-pepper fashion within the arterial
endothelium (Robert-Moreno et al., 2005). This ﬁnding, paired
with the close proximity of Jag1- and Notch1-expressing cells, is
suggestive of inductive signaling between adjacent endothelial
cells. The stochastic development of Notch-sending and Notch-
receiving cells within the hemogenic endothelium may be regu-
lated by Sox17, which directly regulates Notch1 through conserved
binding sites in the Notch1 promoter and has opposing effects on
Notch1 and Jag1 expression (Clarke et al., 2013). Notch signaling
through Jag1-Notch1 interaction results in direct transcriptional
activation of Gata2 within the hemogenic endothelium. However,
the hematopoietic defect of Notch1 mutants is more severe than
the defect of Jag1 mutants, suggesting involvement of additional
Notch ligands (Robert-Moreno et al., 2005, 2008). Dorsal aorta
formation and hematopoietic cluster formation appear normal in
homozygous Jag2 mutants (Robert-Moreno et al., 2008).
Finally, Dll1 maintains arterial identity through regulation of
Neuropilin-1 (Nrp1) and the downstream responsiveness to
VEGFA, but its expression in the endothelium initiates around
E13.5, far after hematopoietic speciﬁcation (Sorensen et al., 2009).
While Dll1 is not expressed within arterial endothelium at E10.5, it
is expressed in cells dispersed throughout the subaortic region
(Yoon et al., 2008). Coculture with Dll1-expressing OP9 cells is
sufﬁcient to rescue hematopoietic colony forming capacity of li-
gand-signaling deﬁcient Mib/ para-splachnopleuric explants
(Yoon et al., 2008). Although these ﬁndings suggest non-en-
dothelial cells near the aorta may contribute to pro-hematopoietic
Notch signaling within the endothelium, it remains unclear whe-
ther Dll1 is important for HSC formation, or whether exogenous
Dll1 is simply sufﬁcient to rescue the function of a different ligand.
Similar to Notch, Vegfa is also required for both arterial and
hematopoietic speciﬁcation, and recent studies have demon-
strated distinct contributions of Vegfa to these processes. Of three
splice isoforms of Vegfa expressed during embryogenesis, the
Vegfa short isoform, Vegfa121, is sufﬁcient to rescue both Hey2 and
runx1 expression following Hedgehog inhibition (Rowlinson and
Gering, 2010). In Xenopus, somitic Eto2 is required for expression
of the medium and long isoforms of Vegfa, that, while dispensible
for vasculogenesis and arterial speciﬁcation, are required for ex-
pression of the hemogenic endothelial markers Runx1, Scl, Gata2,
and Gﬁ1 (Leung et al., 2013). Similarly, knockdown of eto2 in
zebraﬁsh inhibits formation of hemogenic endothelium without
alteration to arterial expression of deltaC, dll4, notch1b and notch3
(Leung et al., 2013). Therefore, rather than ﬁlling a single re-
quirement, Vegfa makes both shared and distinct contributions to
arterial speciﬁcation and hemogenic endothelial patterning.6. Is Notch key to the hemogenic potential of arterial
endothelium
In a number of cases, the extension of arterial gene expressionto venous endothelium confers expression of hematopoietic genes,
and even hematopoietic cell emergence from venous vessels,
providing some insight into the molecular mechanisms that confer
hemogenic potential. In one example, Nrp1 acts as a co-receptor to
VEGFR-2, enhancing the afﬁnity and level of response to Vegfa
within arterial endothelium (Becker et al., 2005; Soker et al., 1998).
Expression of Nrp1 is inhibited in the venous endothelium by
COUP-TFII, which prevents a response to VEGF signaling in these
cells (Gridley, 2007). Endothelial-speciﬁc deletion of COUP-TFII
results in venous expression of arterial markers, including Nrp1,
Hey1, Jag1 and Notch1, as well the formation of ectopic c-Kitþ
CD45þ hematopoietic clusters (You et al., 2005). Similarly, venous
hematopoietic cluster formation accompanies the ectopic expres-
sion of arterial genes in Alk1 and Endoglinmutants (Sorensen et al.,
2003; Urness et al., 2000). In a third instance, constitutively acti-
vated Hedgehog signaling in zebraﬁsh ptc1;ptc2 mutants results in
the expansion of arterial expression to the venous endothelium,
and this is accompanied by ectopic runx1 expression in the pos-
terior cardinal vein (Wilkinson et al., 2012). Finally, whole-embryo
activation of Notch signaling by heat-shock induction of NICD1
results in an expansion of both arterial and hemogenic endothelial
expression in the posterior cardinal vein (Burns et al., 2005).
Therefore, it is possible that the molecular speciﬁcation of arterial
endothelium creates a permissive environment for hematopoietic
development by initiating the expression of Notch ligands and
receptors essential to HSC formation.
Within the context of hematopoiesis, Notch signaling seems to
be a unique element driving HSC potential. To this end, EMPs,
which arise from endothelial cells similarly to HSCs, emerge in-
dependent of Notch signaling (Kumano et al., 2003; Hadland et al.,
2004; Bertrand et al., 2010). Recently, HSCs and EMPs were sug-
gested to arise from distinct endothelial populations, with ex-
pression of Ly6A differentiating aortic endothelial cells with HSC
potential (Chen et al., 2011). Jag1 mutants, which have normal
arterial speciﬁcation, but are deﬁcient in HSC formation, fail to
generate Ly6a-positive cells within the dorsal aorta (Robert-Mor-
eno et al., 2008). Similarly, in vitro programmed hemogenic en-
dothelium requires Notch1 expression to maintain lymphoid po-
tential, with Sox17-Notch-deﬁcient cells generating only deﬁnitive
erythroid and myeloid lineages (Clarke et al., 2013). Taken to-
gether, these reports indicate a key role for Notch signaling in
establishing the hemogenic capacity of the dorsal aorta.7. Somitic signaling contributes to hematopoiesis
Recently, the somites have become implicated as essential
contributors to the hematopoietic speciﬁcation process. The β-
catenin-independent Wnt16 ligand is expressed within the so-
mites and is required for HSC speciﬁcation independently of ar-
terial speciﬁcation (Clements et al., 2011). Somitic expression of
the Notch ligands deltaC and deltaD are downregulated following
wnt16 knockdown. Combined rescue of both ligands is sufﬁcient to
restore expression of hemogenic endothelial markers runx1 and
cmyb within the ﬂoor of the dorsal aorta, while neither alone is
sufﬁcient for rescue (Clements et al., 2011). Thus far it is not clear
why both Notch ligands are needed within the somite. The DeltaC
and DeltaD ligands interact homo- and heterophilically during
somite segmentation (Wright et al., 2011). Although both ligands
are required in this process, DeltaC is sufﬁcient to permit Notch
activation while DeltaD is not, suggesting that signaling occurs
through DeltaC–DeltaC and DeltaC–DeltaD dimers (Wright et al.,
2011). In HSC speciﬁcation, it is unclear whether DeltaC and Del-
taD function redundantly, as heterodimers, or independently with
distinct functions.
The constitutive Hedgehog signaling that occurs in ptc1;ptc2
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a concomitant 89% decrease in runx1 expressing endothelial cells,
due to a simultaneous increase of Vegfa expression and decrease of
wnt16, deltaC and deltaD expression within the somites (Wilkinson
et al., 2012).
Recent studies in the zebraﬁsh embryo have demonstrated
dynamic regulation of HSC speciﬁcation by Fgf signaling, which
ﬁrst promotes hematopoietic speciﬁcation through somitic sig-
naling at 14–17 h post fertilization, and then from creating a re-
strictive environment for HSC emergence from 20.5 h, after the
formation of the vascular cord (Lee et al., 2014; Pouget et al., 2014).
Within the early, positive window, Fgf signaling regulates somitic
expression of deltaC, but not deltaD, through the Wnt16-depen-
dent Fgfr4 receptor (Lee et al., 2014), indicating distinct regulation
of deltaC and deltaD downstream of somitic Wnt16.
Two somitic Notch signaling events are required for HSC for-
mation within the zebraﬁsh embryo: somite-intrinsic Notch sig-
naling and somite-to-PLM Notch signaling (Fig. 2). Interaction
between the migrating PLM cells and the ventral surface of the
somite is mediated by the junctional adhesion molecule Jam1a, on
PLM cells, and its binding partner Jam2a on somitic cells (Ko-
bayashi et al., 2014). Direct contact between the somite and PLM is
required for efﬁcient Notch signal transduction to the PLM. When
the function of either jam1a or jam2a is lost, reduced Notch signal
transmission from the somite to the PLM disrupts hemogenic
endothelial programming, whereas arterial differentiation occurs
normally. The hematopoietic defect resulting from insufﬁcient
somite–PLM contact can be partially rescued by the provision of
exogenous DeltaC, however it is fully rescuable by DeltaD (Ko-
bayashi et al., 2014). Given the inability of DeltaD to individually
activate Notch signaling during somite segmentation, it is possible
that DeltaD may signal more effectively to the adjacent PLM.
Gata2 is a direct transcriptional target of Notch signaling and is
required cell-autonomously for HSC formation prior to the en-
dothelial–hematopoietic transition (Kumano et al., 2003; Hadland
et al., 2004; Robert-Moreno et al., 2005; de Pater et al., 2013). In
zebraﬁsh, the Gata2 homolog Gata2b is speciﬁcally required for
HSC formation (Butko et al., 2015). Expression of gata2b initiates in
the vascular cord during PLM convergence, and is dependent upon
both Wnt16 and endothelial Notch receptors, suggesting that so-
mite-to-PLM Notch signaling directly speciﬁes hemogenic en-
dothelium through Gata2b function.
An in-depth analysis of the tissue-speciﬁc requirements for the
various Notch receptors recently revealed that Notch signaling
must be activated both within the endothelium and the somites in
order for HSC speciﬁcation to proceed normally (Kim et al., 2014).
Of the four Notch receptors in the zebraﬁsh embryo, Notch1a,
Notch1b, and Notch3 are independently required for HSC forma-
tion, whereas Notch2 is not required. Whereas the Notch1
homologs Notch1a and Notch1b function directly within the en-
dothelium, Notch3 is required within the somite and regulates
HSC formation in a non cell-autonomous manner. Notch3 func-
tions epistatically downstream of Wnt16, and combinatorial low-
level knockdowns indicate notch3 is required synergistically with
deltaC and deltaD, suggesting that Notch3 may be activated within
the somite by one or both of these ligands (Fig. 2B). While it is still
unclear how somite-intrinsic Notch activation affects HSC emer-
gence, both Wnt16 and Notch3 are required for the proper for-
mation of the sclerotomal compartment of the somite. The tran-
scription factor Pax9, which marks the sclerotome (Nornes et al.,
1996), was recently shown to be important for HSPC emergence.
Knockdown of pax9 results in the decreased generation of cmyb-
positive cells within the dorsal aorta (Charbord et al., 2014), fur-
ther supporting a contribution to HSC generation by the scler-
otome. Although several lines of evidence have indicated the im-
portance of sclerotome for HSPC speciﬁcation, the exactcontribution this tissue makes is not known. One likely explana-
tion is that correct somite morphology or organization is necessary
for effective transmission of Notch signaling from the somite to the
PLM. It has also been proposed that Notch3-activated somitic cells
may interact directly with the hemogenic endothelium following
dorsal aorta formation, either by incorporating into the aortic wall
or giving rise to the smooth muscle precursors that envelop the
dorsal aorta. In chicken embryos, somite derived cells incorporate
into the aortic endothelium in a Notch-dependent manner (Pouget
et al., 2006; Ohata et al., 2009; Sato et al., 2008). This process
occurs in the period leading up to HSC emergence, and it is con-
ceivable that these cells may relay an unknown hematopoietic
inductive signal. In both mice and chicken embryos, the scler-
otome gives rise to vascular smooth muscle cells that directly
surround the aorta (Pouget et al., 2008; Wasteson et al., 2008).
However, sclerotome-derived smooth muscle cells are not re-
quired for aortic hematopoiesis (Richard et al., 2013), making it
unlikely that the sclerotomal contribution occurs through this
population.8. Proinﬂammatory signaling and HSC emergence
Although embryonic development occurs in a protected en-
vironment under relatively sterile conditions, HSC formation is
preceded by a transient wave of functional primitive myeloid cells.
Recently, inﬂammatory signals produced by these primitive mye-
loid cells were found to be critical for the establishment and ex-
pansion of HSPCs, in part through the regulation of the Notch
pathway.
Proinﬂammatory signaling pathways are heavily activated
within HSPC clusters associated with the mouse dorsal aorta (Li
et al., 2014). The innate inﬂammatory cytokine Interleukin-1 is
expressed in the dorsal aorta and budding hematopoietic cells, and
promotes the activity of nascent HSPCs (Orelio et al., 2008). Types I
and II Interferon produced by primitive myeloid cells activate in-
nate inﬂammatory signaling within the hemogenic endothelium
(Li et al., 2014). Interferon signaling is required for the formation
and expansion of HSPCs, whereas EMP formation occurs in-
dependently of this signal in both mice and zebraﬁsh (Li et al.,
2014). Combined knockdown of tnfa and ifng results in more se-
vere reduction of runx1 expression than loss of either cytokine
individually, suggesting cooperative action by multiple proin-
ﬂammatory cytokines in HSC formation (Li et al., 2014). Tnf, in
particular, is provided by primitive neutrophils, and signals
through Tnfr2 to activate expression of the Notch ligand jag1a in
the aortic endothelium (Espin-Palazon et al., 2014). Similar to the
requirement for Jag1 in mice, zebraﬁsh Jag1a is required for HSC
formation but not arterial speciﬁcation (Robert-Moreno et al.,
2008; Espin-Palazon et al., 2014). Of the two Notch1 homologs,
low level knockdowns of jag1a with notch1a results in a more
severe downregulation of hematopoietic expression, while com-
bined knockdown of jag1a with notch1b does not. This suggests
that Jag1a may signal through the Notch1a receptor to promote
the formation and expansion of HSCs (Fig. 2D). Interestingly, aortic
expression of Jag1 is dependent on Notch signaling in mice (Ro-
bert-Moreno et al., 2005). If Jag1 regulation is conserved, it is
possible that it may represent an intersection of successive
hematopoietic Notch requirements.9. Downregulation of Notch signaling in emerging HSCs
As discussed previously, multiple Notch signaling events posi-
tively regulate HSC speciﬁcation. Notch transcriptional targets,
including Gata2, Hes1, Hrt1 and Hrt2 are expressed in the
E. Butko et al. / Developmental Biology 409 (2016) 129–138 135endothelium and budding clusters within the dorsal aorta (Guiu
et al., 2013; Robert-Moreno et al., 2005; Fischer et al., 2004). Re-
cent evidence from mice suggests that Notch signaling negatively
regulates HSC emergence following the speciﬁcation of hemogenic
endothelial cells and must be down regulated for HSC emergence
to progress. VE-Cadherin:Cre mediated permanent induction of
NICD1 in the endothelium and endothelial-derived cells results in
a surprising lack of hematopoietic clusters within the dorsal aorta
in E10.5 embryos, and a deﬁciency in fetal liver colonization by
Notch-active cells (Tang et al., 2013). Although total loss of Notch
signaling inhibits HSC speciﬁcation, deletion of either Notch1 or
Notch1-regulator Sox17 from E9.5 mouse AGM explants increases
the hematopoietic output of the dorsal aorta (Lizama et al., 2015).
Concordantly, late chemical inhibition of Notch signaling inhibi-
tion results in increased production of CD45þ cells in both mouse
para-splanchnopleura explants and in avian embryos (Richard
et al., 2013). Chemical inhibition of Notch signaling also accelerates
hematopoietic cluster formation, suggesting that Notch actively
delays the onset of the budding process. However, this Notch in-
hibition-mediated hematopoietic expansion is transient, with
newly formed cells undergoing apoptosis under continued Notch
inhibition (Richard et al., 2013).
During normal hematopoietic cluster formation in both mouse
and chicken embryos, Notch activity is downregulated speciﬁcally
in hematopoietic clusters, but maintained in the surrounding
aortic endothelium (Richard et al., 2013; Del Monte et al., 2007).
This drop in Notch activity may result from loss of Sox17, which
promotes Notch1 expression in arterial endotheliumwhile actively
repressing expression of hematopoietic transcription factors
Runx1 and Gata2 (Lizama et al., 2015). The expression of VE-
Cadherin and Dll4 are also downregulated in hematopoietic clus-
ters relative to the aortic endothelium (Richard et al., 2013), sug-
gesting that hematopoietic clusters experience a general loss of
arterial and endothelial identity during EHT. Although both
Notch1 and Notch4 are expressed in the murine dorsal aorta, only
Notch1 must be downregulated, whereas enforced activation of
Notch4 signaling by ectopic NICD4 impairs vascular remodeling
but does not inhibit hematopoiesis (Tang et al., 2013). ConsistentFig. 3. Notch activity in budding hematopoietic cells. (A) Notch signaling is inactivated in
cells in a “Notch-on” active Notch signaling state. Gray coloring indicates cells in a “Not
transgenic zebraﬁsh. Kdrl:Cre; bactin:DsRed labels vascular and vascular-derived cells,
undergoing EHT. Notch signaling is active throughout the dorsal aorta, and budding HSPC
of the zebraﬁsh embryo, it remains unclear whether Tp1:GFPþ budding HSPCs are truly
protein persists.with this, the Notch1 target Hes1 is progressively downregulated
in emergent murine HSPCs as they mature (Richard et al., 2013),
indicating a requirement for down-regulation of the Notch signal
for HSC emergence.
The downregulation of Notch activity in chicken embryos is
directly observable by the reduced ﬂuorescence of the Tp1:Venus
Notch reporter in budding hematopoietic clusters (Richard et al.,
2013). In zebraﬁsh embryos, Tp1:GFP is expressed in arterial en-
dothelium in advance of HSC formation, and is not downregulated
during HSPC budding (Fig. 3). However, epistatic studies in zeb-
raﬁsh have recently suggested that the requirement for Notch
downregulation may be conserved in this system. In zebraﬁsh
embryos, Cfos acts genetically upstream of the Notch-mediated
maintenance of dll4 and ephrinb2a following arterial speciﬁcation
(Wei et al., 2014). Deacetylation of cfos by the transcriptional re-
pressors Ncor2 and Hdac3 is required for HSC emergence, sug-
gesting that the formation of HSCs may be tied to the down-
regulation of arterial identity in zebraﬁsh as well (Wei et al., 2014).
In zebraﬁsh, it is likely that HSPC emergence proceeds too quickly
to yield a noticeable decrease in Tp1:GFP ﬂuorescence. In vivo vi-
sualization of this process may instead require new tools allowing
for the detection of Notch receptor activation in real time.
Tight regulation of the response to Notch1 receptor-mediated
signaling is provided by a type-1 incoherent feed forward loop
(Guiu et al., 2013). To this effect, Notch1 simultaneously controls
expression of transcriptional activators, such as Gata2, and tran-
scriptional repressors, such as Hes1. Following simultaneous acti-
vation of both Gata2 and Hes1, Hes1 provides direct inhibition of
Gata2 expression, resulting in a restricted pulse of the positive
hematopoietic regulator. Loss of Hes1, combined with a loss of
Hes5, results in the formation of large hematopoietic clusters that
lack functionality (Guiu et al., 2013). This phenotype is reminiscent
of the robust, accelerated formation of non-functional
hematopoietic clusters formed under Notch inhibition, suggesting
that Notch-dependent repression of cluster formation occurs via
Hes1 and Hes5. Repression of premature cluster formation is likely
a hematopoietic-speciﬁc process, as Hes1 and Hes5 are dis-
pensable for arterial differentiation (Guiu et al., 2013) and latethe budding hematopoietic clusters of higher vertebrates. Green coloring indicates
ch-off” inactive Notch signaling state. (B) Confocal microscopy of HSPC budding in
and Tp1:GFP labels cells responsive to Notch activity. White arrows indicate cells
s have high levels of Notch reporter GFP at 48hpf. (C) Due to the rapid development
Notch-active, or whether these cells have inactivated Notch signaling while the GFP
E. Butko et al. / Developmental Biology 409 (2016) 129–138136Notch inhibition does not induce hematopoietic clusters in the
vein (Richard et al., 2013).10. Post-emergence hematopoietic contributions of Notch
signaling
Although Notch activity must be downregulated in order to
form hematopoietic clusters that contain functional HSPCs, Notch
signaling is required in multiple capacities post-emergence. Notch
signaling has a well-characterized role in lymphocyte develop-
ment (Radtke et al., 2013). Additionally, a novel role for Notch
signaling was recently identiﬁed in HSPCs following emergence
from the dorsal aorta region. Notch1 hypomorphs successfully
generate functional HSCs that seed the fetal liver, however, these
cells have impaired reconstitutive capacity. Similarly, conditional
deletion of RBPjK following the endothelial to hematopoietic
transition results in similarly impaired competitive reconstitution.
Together, these results suggest a critical, cell-autonomous re-
quirement for Notch signaling that occurs post-emergence, al-
though the underlying molecular mechanism(s) has not been de-
ﬁned. Within the bone marrow niche, Notch signaling induced by
endothelial Jag1 balances the quiescence and self-renewal of long-
term (LT) HSCs, thereby preventing exhaustion of the LT-HSC po-
pulation (Poulos et al., 2013). Similarly, Notch activation restricts
differentiation of primary cord-derived hematopoietic cells while
maintaining normal levels of proliferation (Carlesso et al., 1999). It
is conceivable that Notch signaling may have a similar role in
maintaining a steady pool of the nascent HSC population.11. Conclusion
HSCs are formed through a complex process that has yet to be
fully recapitulated in vitro, suggesting that we still do not under-
stand all requisite aspects of their development. Although Notch
signaling has been known to be an essential component for HSC
generation, recent studies suggest that it makes a far more com-
plex contribution than was previously appreciated. Leading up to
HSC speciﬁcation, Notch signaling promotes the proliferation of
early endothelial cells. In establishing the arterial program, Notch
signaling makes two important contributions to the establishment
of HSCs. First, it allows proper morphological development of the
vasculature, permitting the establishment of circulation, which is
necessary for HSC development, and second, it promotes the ex-
pression of Notch receptors and ligands that are subsequently
required for HSC development. Somite-intrinsic Notch signaling
establishes the sclerotomal compartment of the somite, which
makes an essential, but poorly understood contribution to HSC
speciﬁcation (Kim et al., 2014). Our current understanding sug-
gests the sclerotome presents Notch ligand(s) to the shared vas-
cular precursors of HSCs as they migrate across the ventral face of
the somites to form the vascular cord at the embryonic midline. In
this case, somite-intrinsic and arterial Notch signaling act hier-
archically upstream of the somite-to-PLM signal, on the signal-
sending and signal-receiving cells, respectively. An additional
Notch ligand, Jag1, is induced by proinﬂammatory signaling and
activates Notch1 in an endothelial-intrinsic manner (Robert-Mor-
eno et al., 2008; Espin-Palazon et al., 2014). The number of Notch
signaling events at present represents a puzzle, as we do not yet
understand how the multiple intrinsic Notch signals (arterial, so-
mite-to-PLM, and interendothelial) differ. Do these distinct Notch
signaling events activate different downstream targets, and how is
this achieved? Do they instead raise the overall level of Notch
signaling, allowing for greater target activation? In zebraﬁsh,
where the two involvements of the somite have been described,three of the four Notch receptors are required for hematopoiesis
(Kim et al., 2014), and there is some separation of ligands and
receptors involved in arterial speciﬁcation, somitic signaling, and
interendothelial Notch signaling. However, thus far in mice, only
Notch1 appears essential to the establishment of HSCs. It is not yet
clear whether somite-intrinsic and somite-to-PLM Notch signaling
events are conserved in mammalian species, and it is also unclear
whether Notch1 mediates each signaling event or whether other
receptors may be involved. Further studies focused on ligand–re-
ceptor speciﬁcity, downstream targets, and effects of Notch sig-
naling level on hematopoiesis are necessary. Furthermore, the
need for Notch downregulation within budding hematopoietic
clusters is just beginning to be appreciated. Deﬁning the molecular
mechanisms of Notch shutdown, and the reason it is required for
HSC establishment, may inform future in vitro HSC derivation
strategies.References
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